Abstract 6163: Fusion landscape in acute leukemias: A submerged world of not routinely characterized transcripts
Anna Ferrari(University of Padua), Giovanni Martinelli(University of Bologna), Maria Teresa Bochicchio(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Michela Rondoni(Azienda Unità Sanitaria Locale Della Romagna), Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Giovanni Marconi(University of Bologna), Daniel Remondini(Istituto Nazionale di Fisica Nucleare), Gastone Castellani(University of Bologna), Barbara Giannini(Azienda Unità Sanitaria Locale Della Romagna), Daniele Dall’Olio(University of Bologna), Michela Tebaldi(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Cristina Papayannidis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Chiara Domizio(University of Ferrara), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Silvia Vitali(University of Bologna), Fabio Giglio(IRCCS Ospedale San Raffaele), Crescenza Pasciolla(Istituto Tumori Bari), Sara Galimberti(University of Pisa), Monica Fumagalli(Azienda Ospedaliera San Gerardo), Eugenio Fonzi(University of Bologna)
Cited by 0
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
The STARTEC Decision Support Tool for Better Tradeoffs between Food Safety, Quality, Nutrition, and Costs in Production of Advanced Ready-to-Eat Foods
|BioMed Research International|2017|1.2k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644